1. Home
  2. NLSP vs SPHL Comparison

NLSP vs SPHL Comparison

Compare NLSP & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • SPHL
  • Stock Information
  • Founded
  • NLSP 2015
  • SPHL 2002
  • Country
  • NLSP Switzerland
  • SPHL Singapore
  • Employees
  • NLSP N/A
  • SPHL N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • SPHL Homebuilding
  • Sector
  • NLSP Health Care
  • SPHL Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • SPHL Nasdaq
  • Market Cap
  • NLSP 5.8M
  • SPHL 5.7M
  • IPO Year
  • NLSP 2021
  • SPHL 2024
  • Fundamental
  • Price
  • NLSP $1.62
  • SPHL $0.60
  • Analyst Decision
  • NLSP
  • SPHL
  • Analyst Count
  • NLSP 0
  • SPHL 0
  • Target Price
  • NLSP N/A
  • SPHL N/A
  • AVG Volume (30 Days)
  • NLSP 26.4K
  • SPHL 1.5M
  • Earning Date
  • NLSP 05-27-2025
  • SPHL 02-21-2025
  • Dividend Yield
  • NLSP N/A
  • SPHL N/A
  • EPS Growth
  • NLSP N/A
  • SPHL N/A
  • EPS
  • NLSP N/A
  • SPHL N/A
  • Revenue
  • NLSP N/A
  • SPHL $6,456,601.00
  • Revenue This Year
  • NLSP N/A
  • SPHL N/A
  • Revenue Next Year
  • NLSP N/A
  • SPHL N/A
  • P/E Ratio
  • NLSP N/A
  • SPHL N/A
  • Revenue Growth
  • NLSP N/A
  • SPHL N/A
  • 52 Week Low
  • NLSP $1.30
  • SPHL $0.35
  • 52 Week High
  • NLSP $18.40
  • SPHL $7.80
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 53.77
  • SPHL N/A
  • Support Level
  • NLSP $1.58
  • SPHL N/A
  • Resistance Level
  • NLSP $1.75
  • SPHL N/A
  • Average True Range (ATR)
  • NLSP 0.10
  • SPHL 0.00
  • MACD
  • NLSP 0.01
  • SPHL 0.00
  • Stochastic Oscillator
  • NLSP 55.73
  • SPHL 0.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.

Share on Social Networks: